Master’s Degrees in Clinical and Industrial Drug Development

#1

Temple University

Philadelphia, Pennsylvania

The most popular school in the United States for clinical and industrial drug development students seekinga master's degree is Temple University. Roughly 37,200 attend the school each year. The average in-state tuition for full-time undergraduates is $20,173 per year, while in-state graduate students, on average, pay $20,531 per year. During the most recent year for which we have data, 73 people received their master's degree in clinical and industrial drug development from Temple. Of these students, 75% were women and 29% were members of underrepresented racial-ethnic groups.

#2

University of California - San Diego

La Jolla, California

The 2nd most popular school in the country for clinical and industrial drug development majors who are seeking their master's degree is University of California - San Diego. Roughly 39,500 attend the school each year. The average in-state tuition for full-time undergraduates is $11,564 per year, while in-state graduate students, on average, pay $11,700 per year. During the most recent year for which we have data, 21 people received their master's degree in clinical and industrial drug development from UCSD. About 66% of this group were women, and 53% were students from an underrepresented racial-ethnic group.

#3

University of Washington - Seattle Campus

Seattle, Washington

University of Washington - Seattle Campus comes in at #3 on our list of the most popular colleges offering master's degrees in clinical and industrial drug development. Each year, around 48,100 students seeking various degrees attend the university. The average in-state tuition for full-time undergraduates is $11,189 per year, while in-state graduate students, on average, pay $17,004 per year. During the most recent year for which we have data, 18 people received their master's degree in clinical and industrial drug development from UW Seattle. About 83% of this group were women, and 22% were students from an underrepresented racial-ethnic group.

#4

Campbell University

Buies Creek, North Carolina

The 4th most popular school in the country for clinical and industrial drug development majors who are seeking their master's degree is Campbell University. Each year, around 5,900 students seeking various degrees attend the university. The average in-state tuition for full-time undergraduates is $36,650 per year, while in-state graduate students, on average, pay $14,417 per year. During the most recent year for which we have data, 15 people received their master's degree in clinical and industrial drug development from Campbell. Of these students, 85% were women and 25% were members of underrepresented racial-ethnic groups.

#5

Eastern Michigan University

Ypsilanti, Michigan

Eastern Michigan University is the 5th most popular school in the nation for students seeking a master's degree in clinical and industrial drug development. Roughly 16,200 attend the school each year. The average in-state tuition for full-time undergraduates is $14,500 per year, while in-state graduate students, on average, pay $16,857 per year. During the most recent year for which we have data, 13 people received their master's degree in clinical and industrial drug development from Eastern Michigan. About 75% of this group were women, and 25% were students from an underrepresented racial-ethnic group.

#6

University of Southern California

Los Angeles, California

University of Southern California comes in at #6 on our list of the most popular colleges offering master's degrees in clinical and industrial drug development. Roughly 46,200 attend the school each year. The average in-state tuition for full-time undergraduates is $63,468 per year, while in-state graduate students, on average, pay $63,468 per year. During the most recent year for which we have data, 10 people received their master's degree in clinical and industrial drug development from USC. About 50% of this group were women, and 30% were students from an underrepresented racial-ethnic group.